Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC666220209;20210;20211 chr2:178727594;178727593;178727592chr2:179592321;179592320;179592319
N2AB634519258;19259;19260 chr2:178727594;178727593;178727592chr2:179592321;179592320;179592319
N2A541816477;16478;16479 chr2:178727594;178727593;178727592chr2:179592321;179592320;179592319
N2BNoneNone chr2:Nonechr2:None
Novex-1NoneNone chr2:Nonechr2:None
Novex-2NoneNone chr2:Nonechr2:None
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: L
  • RefSeq wild type transcript codon: CTT
  • RefSeq wild type template codon: GAA
  • Domain: Ig-50
  • Domain position: 89
  • Structural Position: 175
  • Q(SASA): 0.2379
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
L/F rs2079581150 None 0.006 N 0.14 0.13 0.38342384377 gnomAD-4.0.0 1.72006E-06 None None None None N None 0 0 None 0 0 None 0 0 0 1.64447E-05 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
L/A 0.1552 likely_benign 0.1375 benign -1.222 Destabilizing 0.495 N 0.435 neutral None None None None N
L/C 0.5087 ambiguous 0.4448 ambiguous -0.691 Destabilizing 0.995 D 0.427 neutral None None None None N
L/D 0.4184 ambiguous 0.3734 ambiguous -0.606 Destabilizing 0.543 D 0.565 neutral None None None None N
L/E 0.1912 likely_benign 0.1935 benign -0.663 Destabilizing 0.031 N 0.45 neutral None None None None N
L/F 0.0957 likely_benign 0.089 benign -0.985 Destabilizing 0.006 N 0.14 neutral N 0.385045462 None None N
L/G 0.4327 ambiguous 0.379 ambiguous -1.474 Destabilizing 0.543 D 0.557 neutral None None None None N
L/H 0.1323 likely_benign 0.1223 benign -0.693 Destabilizing 0.927 D 0.515 neutral N 0.472144371 None None N
L/I 0.0787 likely_benign 0.0728 benign -0.64 Destabilizing 0.006 N 0.253 neutral N 0.403649865 None None N
L/K 0.2046 likely_benign 0.2013 benign -0.704 Destabilizing 0.704 D 0.522 neutral None None None None N
L/M 0.0927 likely_benign 0.0908 benign -0.444 Destabilizing 0.176 N 0.295 neutral None None None None N
L/N 0.2423 likely_benign 0.2048 benign -0.428 Destabilizing 0.017 N 0.457 neutral None None None None N
L/P 0.6377 likely_pathogenic 0.6192 pathogenic -0.801 Destabilizing 0.975 D 0.553 neutral N 0.520706322 None None N
L/Q 0.0989 likely_benign 0.1011 benign -0.68 Destabilizing 0.893 D 0.523 neutral None None None None N
L/R 0.1363 likely_benign 0.1406 benign -0.082 Destabilizing 0.863 D 0.525 neutral N 0.455193406 None None N
L/S 0.1571 likely_benign 0.1328 benign -0.987 Destabilizing 0.543 D 0.518 neutral None None None None N
L/T 0.116 likely_benign 0.1059 benign -0.935 Destabilizing 0.013 N 0.159 neutral None None None None N
L/V 0.0767 likely_benign 0.0732 benign -0.801 Destabilizing 0.27 N 0.337 neutral N 0.420888832 None None N
L/W 0.1771 likely_benign 0.1732 benign -0.994 Destabilizing 0.995 D 0.483 neutral None None None None N
L/Y 0.2382 likely_benign 0.2241 benign -0.766 Destabilizing 0.807 D 0.468 neutral None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.